Literature DB >> 30964586

The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation.

Meng Li1, Caroline S Bennette2, Laura M Amendola3, M Ragan Hart3, Patrick Heagerty4, Bryan Comstock4, Peter Tarczy-Hornoch5, Stephanie M Fullerton6, Dean A Regier7, Wylie Burke6, Susan B Trinidad6, Gail P Jarvik3, David L Veenstra1, Donald L Patrick8.   

Abstract

The purpose of this study was to develop a brief instrument, the Feelings About genomiC Testing Results (FACToR), to measure the psychosocial impact of returning genomic findings to patients in research and clinical practice. To create the FACToR, we modified and augmented the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire based on findings from a literature review, two focus groups (N = 12), and cognitive interviews (N = 6). We evaluated data from 122 participants referred for evaluation for inherited colorectal cancer or polyposis from the New EXome Technology in (NEXT) Medicine Study, an RCT of exome sequencing versus usual care. We assessed floor and ceiling effects of each item, conducted principal component analysis to identify subscales, and evaluated each subscale's internal consistency, test-retest reliability, and construct validity. After excluding items that were ambiguous or demonstrated floor or ceiling effects, 12 items forming four distinct subscales were retained for further analysis: negative emotions, positive feelings, uncertainty, and privacy concerns. All four showed good internal consistency (0.66-0.78) and test-retest reliability (0.65-0.91). The positive feelings and the uncertainty subscales demonstrated known-group validity. The 12-item FACToR with four subscales shows promising psychometric properties on preliminary evaluation in a limited sample and needs to be evaluated in other populations.
© 2018 National Society of Genetic Counselors.

Entities:  

Keywords:  Colorectal cancer; Genomic testing; Instrument development and validation; Psychological impact

Mesh:

Year:  2018        PMID: 30964586     DOI: 10.1007/s10897-018-0286-9

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  16 in total

1.  The genome empowerment scale: An assessment of parental empowerment in families with undiagnosed disease.

Authors:  Allyn McConkie-Rosell; Kelly Schoch; Jennifer Sullivan; Heidi Cope; Rebecca Spillmann; Christina G S Palmer; Loren Pena; Yong-Hui Jiang; Nicole Daniels; Nicole Walley; Khoon G Tan; Stephen R Hooper; Vandana Shashi
Journal:  Clin Genet       Date:  2019-10-08       Impact factor: 4.438

2.  Clinical exome sequencing vs. usual care for hereditary colorectal cancer diagnosis: A pilot comparative effectiveness study.

Authors:  Xin Niu; Laura M Amendola; Ragan Hart; Caroline S Bennette; Patrick Heagerty; Martha Horike-Pyne; Susan B Trinidad; Elisabeth A Rosenthal; Bryan Comstock; Chris Nefcy; Fuki M Hisama; Robin L Bennett; William M Grady; Carlos J Gallego; Peter Tarczy-Hornoch; Stephanie M Fullerton; Wylie Burke; Dean A Regier; Michael O Dorschner; Brian H Shirts; Peggy D Robertson; Deborah A Nickerson; Donald L Patrick; Gail P Jarvik; David L Veenstra
Journal:  Contemp Clin Trials       Date:  2019-08-07       Impact factor: 2.226

Review 3.  Conceptualization of utility in translational clinical genomics research.

Authors:  Hadley Stevens Smith; Kyle B Brothers; Sara J Knight; Sara L Ackerman; Christine Rini; David L Veenstra; Amy L McGuire; Benjamin S Wilfond; Janet Malek
Journal:  Am J Hum Genet       Date:  2021-10-22       Impact factor: 11.025

4.  Creating accessible Spanish language materials for Clinical Sequencing Evidence-Generating Research consortium genomic projects: challenges and lessons learned.

Authors:  Nangel M Lindberg; Amanda M Gutierrez; Kathleen F Mittendorf; Michelle A Ramos; Beatriz Anguiano; Frank Angelo; Galen Joseph
Journal:  Per Med       Date:  2021-08-27       Impact factor: 2.119

5.  Mixed-methods evaluation of the NHS Genomic Medicine Service for paediatric rare diseases: study protocol [version 1; peer review: 2 approved, 2 approved with reservations].

Authors:  Celine Lewis; James Buchannan; Angus Clarke; Emma Clement; Bettina Friedrich; Jillian Hastings-Ward; Melissa Hill; Ruth Horn; Anneke M Lucassen; Chris Patch; Alexandra Pickard; Lauren Roberts; Saskia C Sanderson; Sarah L Lewell; Cecilia Vindrola-Padros; Monica Lakhanpaul
Journal:  NIHR Open Res       Date:  2021-11-22

6.  Psychological outcomes related to exome and genome sequencing result disclosure: a meta-analysis of seven Clinical Sequencing Exploratory Research (CSER) Consortium studies.

Authors:  Jill O Robinson; Julia Wynn; Barbara Biesecker; Leslie G Biesecker; Barbara Bernhardt; Kyle B Brothers; Wendy K Chung; Kurt D Christensen; Robert C Green; Amy L McGuire; M Ragan Hart; Ida Griesemer; Donald L Patrick; Christine Rini; David Veenstra; Angel M Cronin; Stacy W Gray
Journal:  Genet Med       Date:  2019-06-13       Impact factor: 8.822

7.  Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations.

Authors:  Kathleen F Mittendorf; Tia L Kauffman; Laura M Amendola; Katherine P Anderson; Barbara B Biesecker; Michael O Dorschner; Devan M Duenas; Donna J Eubanks; Heather Spencer Feigelson; Marian J Gilmore; Jessica Ezzell Hunter; Galen Joseph; Stephanie A Kraft; Sandra Soo Jin Lee; Michael C Leo; Elizabeth G Liles; Nangel M Lindberg; Kristin R Muessig; Sonia Okuyama; Kathryn M Porter; Leslie S Riddle; Bradley A Rolf; Alan F Rope; Jamilyn M Zepp; Gail P Jarvik; Benjamin S Wilfond; Katrina A B Goddard
Journal:  Contemp Clin Trials       Date:  2021-05-11       Impact factor: 2.261

8.  Psychological impact of genetic and clinical screening for pulmonary fibrosis on asymptomatic first-degree relatives of affected individuals.

Authors:  Nikkola Carmichael; Jose M Martinez Manzano; Luisa D Quesada-Arias; Sergio de Frías Poli; Maura Alvarez Baumgartner; Maria A Planchart Ferretto; Lisa DiGianni; Shannon Gampala-Sagar; Dominick A Leone; Swati Gulati; Souheil Y El-Chemaly; Hilary J Goldberg; Rachel Putman; Hiroto Hatabu; Ivan O Rosas; Gary M Hunninghake; Benjamin A Raby
Journal:  Thorax       Date:  2021-01-22       Impact factor: 9.102

9.  The NYCKidSeq project: study protocol for a randomized controlled trial incorporating genomics into the clinical care of diverse New York City children.

Authors:  Jacqueline A Odgis; Katie M Gallagher; Sabrina A Suckiel; Katherine E Donohue; Michelle A Ramos; Nicole R Kelly; Gabrielle Bertier; Christina Blackburn; Kaitlyn Brown; Lena Fielding; Jessenia Lopez; Karla Lopez Aguiniga; Estefany Maria; Jessica E Rodriguez; Monisha Sebastin; Nehama Teitelman; Dana Watnick; Nicole M Yelton; Avinash Abhyankar; Noura S Abul-Husn; Aaron Baum; Laurie J Bauman; Jules C Beal; Toby Bloom; Charlotte Cunningham-Rundles; George A Diaz; Siobhan Dolan; Bart S Ferket; Vaidehi Jobanputra; Patricia Kovatch; Thomas V McDonald; Patricia E McGoldrick; Rosamond Rhodes; Michael L Rinke; Mimsie Robinson; Arye Rubinstein; Lisa H Shulman; Christian Stolte; Steven M Wolf; Elissa Yozawitz; Randi E Zinberg; John M Greally; Bruce D Gelb; Carol R Horowitz; Melissa P Wasserstein; Eimear E Kenny
Journal:  Trials       Date:  2021-01-14       Impact factor: 2.279

10.  Clinical and psychological outcomes of receiving a variant of uncertain significance from multigene panel testing or genomic sequencing: a systematic review and meta-analysis.

Authors:  Chloe Mighton; Salma Shickh; Elizabeth Uleryk; Petros Pechlivanoglou; Yvonne Bombard
Journal:  Genet Med       Date:  2020-09-14       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.